Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.1%

2 terminated out of 22 trials

Success Rate

84.6%

-1.9% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed with results

Key Signals

1 with results85% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (10)
P 1 (4)
P 2 (1)
P 3 (1)

Trial Status

Completed11
Unknown4
Recruiting3
Terminated2
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

84.6%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT07317284Not ApplicableCompletedPrimary

Evaluation and Treatment for Diabetic Peripheral Neuropathy

NCT03685253Phase 1TerminatedPrimary

Nicotinamide Riboside for Diabetic Neuropathy

NCT07122726Not ApplicableRecruiting

Additional Effects of Proprioceptive Neuromuscular Facilitation With Otago Exercises on Fall Risk in Diabetes Mellitus Patients

NCT06463015Not ApplicableCompleted

Posterior Tibial Nerve PRF for Diabetic Neuropathic Pain

NCT06201611Phase 2RecruitingPrimary

Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy.

NCT05921097Completed

Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes

NCT05642143Recruiting

Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy

NCT05461274Not Yet Recruiting

Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients

NCT05977465Phase 1CompletedPrimary

Empagliflozin in Treatment of Peripheral Diabetic Neuropathy

NCT03888872Not ApplicableCompletedPrimary

Effect of High Tone Power Therapy on Neurophysiological Measures and Function Outcome in Patients With Diabetic Neuropathy

NCT05558878Not ApplicableUnknownPrimary

Effect of Ambroxol in Diabetic Peripheral Neuropathy

NCT05299918Completed

Diabetic Neuropathy Rapid Screening Test in Turkish Patients With Type 2 Diabetes: Sudoscan

NCT04253860Phase 3TerminatedPrimary

Effect of Transcutaneous Electrical Nerve Stimulation in Diabetic Neuropathy

NCT04841720Phase 1Unknown

A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets

NCT03847779Not ApplicableCompletedPrimary

Microcirculatory Vasomotor Changes in Type 2 Diabetes With Peripheral Neuropathy

NCT03455543Not ApplicableCompletedPrimary

Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy

NCT03988413Phase 1CompletedPrimary

Study on Safety, Absorption and Metabolism of SYHA1402 Tablets in Healthy People

NCT03907189UnknownPrimary

Ambulation as a Factor on Oscillating Thermometry

NCT03440203CompletedPrimary

Prevalence of Peripheral Neuropathy and Its Impact on Activities of Daily Living in Patients With Type 2 Diabetes

NCT03725917Not ApplicableUnknown

Patients With Diabetic Neuropathy Who Receive Physiotherapy Treatment Will Have a Decrease in Diabetic Foot Ulcers

Scroll to load more

Research Network

Activity Timeline